{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-031741","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2023-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.585511+00:00","generated_at":"2026-06-10T23:17:26.707747+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NanoVibronix to present positive UroShield study at ICS 2023; reduces CAUTI and blockages","bullets":["Dr. Sandra Wilks to present UroShield study at ICS 2023 in Toronto on September 27.","University of Southampton study shows UroShield reduces catheter-associated urinary tract infections and blockages.","Study suggests UroShield may promote healthy urinary microbiome and reduce antibiotic use.","UroShield uses low-frequency ultrasound to prevent bacterial biofilm on catheters."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-031741","json":"https://secwatch.observer/filing/0001493152-23-031741.json","markdown":"https://secwatch.observer/filing/0001493152-23-031741.md","text":"https://secwatch.observer/filing/0001493152-23-031741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223031741/0001493152-23-031741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223031741/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:17:26.707747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}